Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Mordant

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Transplantation|February 23, 2018
Donor Club Cell Secretory Protein G38A Polymorphism Is Associated With a Decreased Risk of Primary Graft Dysfunction in the French Cohort in Lung TransplantationAngela Hin, Caroline Kannengiesser, Arnaud Roussel, et al.
Clinical Lung Cancer|September 30, 2022
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France StudyPierre Mordant, Solenn Brosseau, Bernard Milleron, et al.
Lung Cancer (Amsterdam, Netherlands)|March 7, 2026
Club cell secretory protein (CCSP) serum concentration is a prognostic factor after surgical resection of localized non-small cell lung cancer in patients in the IFCT-0302 trialSolenn Brosseau, Harry Etienne, Katell Peoc'h, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 2, 2026
Impact of pre-transplantation exposure to immunosuppressive agents on lung transplant outcomes in interstitial lung diseaseKarim Tazibet, Vincent Bunel, Hervé Mal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 7, 2025
No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled ColistinNathalie Grall, Maksud Assadi, Marina Esposito-Farese, et al.
ERJ Open Research|October 29, 2025
Is <i>MUC5B</i> rs35705950 promoter polymorphism associated with chronic lung allograft dysfunction?Adèle Sandot, Ibrahima Ba, Clément R Massonnaud, et al.
Respiratory Medicine and Research|March 28, 2026
French organ procurement organisation agence de la biomédecine 2024 report for lung transplantationAdrien Tissot, Naïssa Bacar, Laurence Beaumont, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 3, 2019
Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantationDaisuke Nakajima, Yui Watanabe, Akihiro Ohsumi, et al.
Neuroendocrinology|February 5, 2020
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid MorphologyJerôme Cros, Nathalie Théou-Anton, Valérie Gounant, et al.
The European Respiratory Journal|July 7, 2018
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcomeOlivier Brugière, Antoine Roux, Jerome Le Pavec, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Transplantation|February 23, 2018
Donor Club Cell Secretory Protein G38A Polymorphism Is Associated With a Decreased Risk of Primary Graft Dysfunction in the French Cohort in Lung TransplantationAngela Hin, Caroline Kannengiesser, Arnaud Roussel, et al.
Clinical Lung Cancer|September 30, 2022
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France StudyPierre Mordant, Solenn Brosseau, Bernard Milleron, et al.
Lung Cancer (Amsterdam, Netherlands)|March 7, 2026
Club cell secretory protein (CCSP) serum concentration is a prognostic factor after surgical resection of localized non-small cell lung cancer in patients in the IFCT-0302 trialSolenn Brosseau, Harry Etienne, Katell Peoc'h, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 2, 2026
Impact of pre-transplantation exposure to immunosuppressive agents on lung transplant outcomes in interstitial lung diseaseKarim Tazibet, Vincent Bunel, Hervé Mal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 7, 2025
No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled ColistinNathalie Grall, Maksud Assadi, Marina Esposito-Farese, et al.
ERJ Open Research|October 29, 2025
Is <i>MUC5B</i> rs35705950 promoter polymorphism associated with chronic lung allograft dysfunction?Adèle Sandot, Ibrahima Ba, Clément R Massonnaud, et al.
Respiratory Medicine and Research|March 28, 2026
French organ procurement organisation agence de la biomédecine 2024 report for lung transplantationAdrien Tissot, Naïssa Bacar, Laurence Beaumont, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 3, 2019
Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantationDaisuke Nakajima, Yui Watanabe, Akihiro Ohsumi, et al.
Neuroendocrinology|February 5, 2020
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid MorphologyJerôme Cros, Nathalie Théou-Anton, Valérie Gounant, et al.
The European Respiratory Journal|July 7, 2018
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcomeOlivier Brugière, Antoine Roux, Jerome Le Pavec, et al.
Pageof 14